 Financial highlights
 
REVENUE (+12.0%)
£856.0m
2013: £764.5 million 
OPERATING CASHFLOW BEFORE 
EXCEPTIONAL ITEMS*** (+47.7%) 
£164.2m
2013: £111.2m
2014 £856.0m
2013 £764.5m
2012 £738.9m
2011 £674.0m
2014 £164.2m
2013 £111.2m
PATIENT DISCHARGES (+10.2%) 
(IN-PATIENT AND DAYCASE) 
260.3k
2013: 236.2k
ADJUSTED, DILUTED EARNINGS  
PER SHARE**
18.3p
260.3k
236.2k
232.6k
223.1k
2014
2013
2012
2011
2009
2014 18.3p
 
ADJUSTED EBITDA* (+6.1%) 
£159.2m
2013: £150.0 million 
 
PROFIT FOR THE YEAR
£6.0m
2014 £159.2m
2013 £150.0m
2014 £6.0m
OPERATING PROFIT BEFORE  
EXCEPTIONAL ITEMS (+2.7%)
£114.1m
2013: £111.1 million 
PROPOSED FINAL DIVIDEND PER SHARE, 
PENCE 
1.8p
2014 £114.1m
2013 £111.1m
2014 1.8p
Contents
STRATEGIC REPORT
01 Financial highlights
02 Spire at a glance
04 Chairman’s statement
06	 C h i ef 	 E x ec ut i v e 	 O f fi c e r’ s 	 st a t e m e n t	
12 Our market 
14 Our business model 
16 The Spire difference 
18 Our strategy 
24 Key performance indicators 
28 Financial review 
38 Clinical review 
40 Operating review
42 Our people
44  Corporate social responsibility
48 Risk management and internal control
52 Principal risks
GOVERNANCE
56 Our Board of Directors
58 Executive management team 
59 Chairman’s governance letter
60 Corporate governance
67  Audit and Risk Committee Report
70  Clinical Governance and  
Safety Committee Report
72 Nomination Committee Report 
74 Directors’ Remuneration Report
89 Directors’ Report
92  Statement of directors’ responsibilities
FINANCIAL STATEMENTS
93 Independent auditor’s Report
9 7	 C o n s o l i d a t ed 	 fi n a n c i a l 	 st a t e m e n ts
1 0 2 	 N ot e s 	 t o 	 t h e 	 fi n a n c i a l 	 st a t e m e n ts
1 2 7	 	 P a r e n t 	 C o m p a n y 	 fi n a n c i a l	 st a t e m e n t s
SHAREHOLDER INFORMATION
133 Additional shareholder information
135 Glossary 
*  Operating profit, adjusted to add back depreciation 
and exceptional items and to adjust the comparator to 
conform the property rental base, referred to hereafter 
as ‘Adjusted EBITDA’. 
**  Calculated as pro-forma profit after tax divided by the 
number of ordinary shares in issue on Admission. Pro-forma 
profit is calculated as earnings after tax adjusted for the 
capital restructuring, exceptional items and the profit 
on asset disposal (detailed on page 34).
***  Operating cashflow adjusted to add back the cashflow 
effect of exceptional items.
Spire Healthcare Group plc Annual Report 2014 01
Strategic Report
Governance
Financial Statements
Shareholder Information
